Reshape Lifesciences Inc (NAS:RSLS)
$ 7.99 1.494 (23%) Market Cap: 4.05 Mil Enterprise Value: 2.40 Mil PE Ratio: 0 PB Ratio: 1.33 GF Score: 66/100

ReShape Lifesciences Inc at OTC Markets Life Science Investor Forum Transcript

Jun 22, 2023 / 03:00PM GMT
Release Date Price: $104.4 (-11.33%)
Matt Liteplo
OTC Markets Group Inc. - Moderator

Hello, and welcome to Virtual Investor Conferences. My name is Matt Liteplo. And on behalf of OTC Markets, we're very pleased you have joined us for our next live presentation from ReShape Lifesciences, a global weight loss and metabolic health solutions company.

(Event Instructions) At this point, I'm very pleased to welcome Paul Hickey, President and CEO; and Tom Stankovich, Chief Financial Officer of ReShape Lifesciences Inc., which trades on Nasdaq under the symbol RSLS. Welcome, Paul and Tom.

Paul Hickey
ReShape Lifesciences Inc. - President & CEO

Thank you, Matt, and thank you, everyone, for joining us this morning. I'm going to spend some time talking about ReShape, the market we serve, and our strategies that drive growth for us.

And before I start, I'd like you to take a look at Fiona. Fiona and I, when we chatted several months ago, she shared her story with me. Fiona received our ReShape product, our Lap-Band, over four years ago. And she did so because she felt like many of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot